<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------
SCHEDULE 13D
Under the Securities Exchange Act of 1934
-------------
(Amendment No. 2)
UroHealth Systems, Inc.
- --------------------------------------------------------------------------
(Name of Issuer)
Common Stock 917272-10-6
par value $.001 per share
- ----------------------------------- -----------------------------------
(Title of class of securities) (CUSIP number)
John G. Murray
FoxMeyer Corporation
1220 Senlac Drive, Carrollton, Texas 75006
- --------------------------------------------------------------------------
(Name, address and telephone number of person authorized to receive
notices and communications)
June 19, 1996
- --------------------------------------------------------------------------
(Date of event which requires filing of this statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the
following box [_].
Check the following box if a fee is being paid with the statement [_].
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent
of the class of securities described in Item 1; and (2) has filed no
amendment subsequent thereto reporting beneficial ownership of five
percent or less of such class.) (See Rule 13d-7.)
Note: When filing this statement in paper format, six copies of this
statement, including exhibits, should be filed with the Commission. See
Rule 13d-1(a) for other parties to whom copies are to be sent.
(Continued on following page(s))
(Page 1 of 3 Pages)
<PAGE>
<PAGE>
CUSIP No. 917272-10-6 13D Page of 3
1 NAME OF REPORTING PERSON: FoxMeyer Corporation
S.S. OR I.R.S. IDENTIFICATION NO. 75-2547851
OF ABOVE PERSON:
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [_]
(b) [_]
3 SEC USE ONLY
4 SOURCE OF FUNDS: 00
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS [_]
REQUIRED PURSUANT TO ITEM 2(d) OR 2(e):
6 CITIZENSHIP OR PLACE OF Delaware
ORGANIZATION:
NUMBER OF 7 SOLE VOTING POWER: 0
SHARES
BENEFICIALLY 8 SHARED VOTING POWER: 0
OWNED BY
EACH 9 SOLE DISPOSITIVE POWER: 0
REPORTING
PERSON WITH 10 SHARED DISPOSITIVE 0
POWER:
11 AGGREGATE AMOUNT BENEFICIALLY 0
OWNED BY REPORTING PERSON:
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) [_]
EXCLUDES CERTAIN SHARES:
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): 0%
14 TYPE OF REPORTING PERSON: CO
<PAGE>
<PAGE>
This Amendment No. 2 to Schedule 13D amends the Statement on
Schedule 13D filed on or about October 11, 1995 by FoxMeyer
Corporation (the "Company") and the Amendment to Schedule 13D filed by
the Company on or about June 4, 1996, with respect to the UroHealth
Systems, Inc., a Delaware corporation formerly known as Davstar
Industries Ltd. (the "Issuer").
Item 5. Interest in Securities of the Issuer.
------------------------------------
(a) On June 19, 1996, the Board of Directors of the Company
declared and distributed a dividend of all securities it owned of the
Issuer to its parent, FoxMeyer Health Corporation. The securities
consisted of 1,414,827 shares of the Issuer's common stock and two
warrants to purchase the Issuer's common stock, all of which are
described in the Amendment to Schedule 13D filed by the Company on or
about June 4, 1996.
(b) Not applicable.
(c) Not applicable.
(d) Not applicable.
(e) On June 19, 1996, the Company ceased to be the beneficial
owner of all of the shares of the Issuer's common stock previously
reported on Schedule 13D, as amended, to be beneficially owned by it.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this Statement is
true, complete and correct.
DATE: June 28, 1996.
SIGNED: FOXMEYER CORPORATION
By: /s/ John G. Murray
--------------------------------
John G. Murray
Assistant Treasurer
<PAGE>
